CIK: 1783165 - Address: C/O Adjuvant Capital, L.P., 501 Fifth Avenue, Suite 1404, New York, NY 10017
2 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/24/22 16:51
3/29/22
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTP.ad2,50015.00016772,597M
3/31/22 20:15
3/29/22
ANTXAn2 Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsAdjuvant Global Health Technology Fund, L.P.NYTP.d2,50015.00016772,597I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact